Stock Events

Stock Events

Trevi Therapeutics (TRVI) Q2 2024 Earnings

7MayConfirmed

Q2 2023

Q3 2023

Q4 2023

Q2 2024

-0.11

-0.1

-0.08

-0.07

Details

Expected EPS

-0.0873

Actual EPS

-0.11

Surprise EPS

-0.02

Surprise Percent

+26%

Description

Trevi Therapeutics (TRVI) has reported earnings of -0.11 per share for Q2 2024.

0 Comments

Share your thoughts

Get the Stock Events App

Sign up for a Stock Events account to create your own watchlists and track your portfolio or dividends.